Brainreader
1 known investors
Brainreader provides FDA-cleared AI software for automated brain volumetric analysis from routine MRI scans. The platform quantifies 83 brain structures to detect subtle atrophy patterns and enhance diagnostic confidence in neurodegenerative disease detection for clinicians and imaging centers.